Kenneth A. Burdick
Chief Executive Officer at LifeStance Health Group Inc.
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: Centene Corporation, 3 years.
Centene Corporation
Director
LifeStance Health Group Inc.
Director · Chief Executive Officer
Chief executive roles
LifeStance Health Group Inc.
· Chief Executive Officer
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 30, 2024 | Centene Corporation | Grant or award | +452 | — | — |
| May 14, 2024 | Centene Corporation | Grant or award | +2,916 | — | — |
| Mar 31, 2024 | Centene Corporation | Grant or award | +389 | — | — |
| Mar 15, 2024 | LifeStance Health Group Inc. | Open-market sale | −214,605 | $6.28 | $1,347,719 |
| Mar 8, 2024 | LifeStance Health Group Inc. | Grant or award | +364,077 | — | — |
| Mar 8, 2024 | LifeStance Health Group Inc. | Grant or award | +423,790 | — | — |
| Feb 6, 2024 | Centene Corporation | Grant or award | +18,563 | — | — |
| Feb 6, 2024 | Centene Corporation | Shares withheld for tax | −33,066 | $74.07 | $2,449,199 |
| Dec 31, 2023 | Centene Corporation | Grant or award | +485 | — | — |
| Sep 30, 2023 | Centene Corporation | Grant or award | +526 | — | — |
| Jun 30, 2023 | Centene Corporation | Grant or award | +525 | — | — |
| May 10, 2023 | Centene Corporation | Grant or award | +2,947 | — | — |
| Mar 31, 2023 | Centene Corporation | Grant or award | +493 | — | — |
| Mar 6, 2023 | LifeStance Health Group Inc. | Grant or award | +1,816,239 | — | — |
| Mar 6, 2023 | LifeStance Health Group Inc. | Grant or award | +544,871 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.